These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2332816)

  • 1. Pathophysiology of proteinuria in diabetic glomerular disease.
    Myers BD
    J Hypertens Suppl; 1990 Mar; 8(1):S41-6. PubMed ID: 2332816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of proteinuria in immune glomerular injury.
    Myers BD
    Am J Nephrol; 1990; 10 Suppl 1():19-23. PubMed ID: 1701613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of proteinuria in diabetic nephropathy. II. A study of the size-selective glomerular filtration barrier.
    Friedman S; Jones HW; Golbetz HV; Lee JA; Little HL; Myers BD
    Diabetes; 1983 May; 32 Suppl 2():40-6. PubMed ID: 6086024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional nature of glomerular injury in progressive diabetic glomerulopathy.
    Tomlanovich S; Deen WM; Jones HW; Schwartz HC; Myers BD
    Diabetes; 1987 May; 36(5):556-65. PubMed ID: 2436961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy.
    Morelli E; Loon N; Meyer T; Peters W; Myers BD
    Diabetes; 1990 Jan; 39(1):76-82. PubMed ID: 1698674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinuria and functional characteristics of the glomerular barrier in diabetic nephropathy.
    Carrie BJ; Myers BD
    Kidney Int; 1980 May; 17(5):669-76. PubMed ID: 6157049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular function in advanced human diabetic nephropathy.
    Winetz JA; Golbetz HV; Spencer RJ; Lee JA; Myers BD
    Kidney Int; 1982 May; 21(5):750-6. PubMed ID: 6180214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charge selectivity of proteinuria in diabetic glomerulopathy.
    Nakamura Y; Myers BD
    Diabetes; 1988 Sep; 37(9):1202-11. PubMed ID: 3410164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of proteinuria in diabetic renal disease.
    Meyer TW
    Semin Nephrol; 1990 May; 10(3):194-202. PubMed ID: 2190277
    [No Abstract]   [Full Text] [Related]  

  • 10. Selectivity of the glomerular filtration barrier in healthy and nephrotic humans.
    Myers BD; Guasch A
    Am J Nephrol; 1993; 13(5):311-7. PubMed ID: 8116683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular size-selectivity and microalbuminuria in early diabetic glomerular disease.
    Scandling JD; Myers BD
    Kidney Int; 1992 Apr; 41(4):840-6. PubMed ID: 1381005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of colloid volume expansion on glomerular barrier size-selectivity in humans.
    Shemesh O; Deen WM; Brenner BM; McNeely E; Myers BD
    Kidney Int; 1986 Apr; 29(4):916-23. PubMed ID: 3712975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slope of serial glomerular filtration rate and the progression of diabetic glomerular disease.
    Austin SM; Lieberman JS; Newton LD; Mejia M; Peters WA; Myers BD
    J Am Soc Nephrol; 1993 Jan; 3(7):1358-70. PubMed ID: 8439648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of proteinuria in diabetic nephropathy: a study of glomerular barrier function.
    Myers BD; Winetz JA; Chui F; Michaels AS
    Kidney Int; 1982 Apr; 21(4):633-41. PubMed ID: 6178872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of exercise on glomerular passage of macromolecules in patients with diabetic nephropathy and in healthy subjects.
    Ala-Houhala I
    Scand J Clin Lab Invest; 1990 Feb; 50(1):27-33. PubMed ID: 1690442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular sieving of high molecular weight proteins in proteinuric rats.
    Bertolatus JA; Abuyousef M; Hunsicker LG
    Kidney Int; 1987 Jun; 31(6):1257-66. PubMed ID: 3613403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenicity of glomerular hyperfiltration, a question of glomerular tolerance?].
    Wüstenberg PW; Dabels J
    Z Gesamte Inn Med; 1990 Apr; 45(8):210-4. PubMed ID: 2198716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade.
    Ruggenenti P; Mosconi L; Sangalli F; Casiraghi F; Gambara V; Remuzzi G; Remuzzi A
    Kidney Int; 1999 Mar; 55(3):984-94. PubMed ID: 10027935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of proteinuria in human glomerulonephritis.
    Myers BD; Okarma TB; Friedman S; Bridges C; Ross J; Asseff S; Deen WM
    J Clin Invest; 1982 Oct; 70(4):732-46. PubMed ID: 6181095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular permselectivity in early stages of overt diabetic nephropathy.
    Andersen S; Blouch K; Bialek J; Deckert M; Parving HH; Myers BD
    Kidney Int; 2000 Nov; 58(5):2129-37. PubMed ID: 11044234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.